Cell Therapy for Knee Osteoarthritis Shows Early Promise: What a New Phase 2a Trial Means for Stem Cell Knee Treatment
Knee osteoarthritis (OA) affects millions of people, and for years the options have mostly been pain management, injections, or knee replacement surgery. A new clinical trial presented at the American College of Rheumatology (ACR) annual meeting suggests cell-based therapy could change that. Here is what the study found, what it does not prove, and how it relates to the stem cell knee treatment we offer at Dream Body Clinic.
What did the study find?
The trial tested a cell-based therapy called OSCA in patients with moderate knee osteoarthritis. The results were presented by Jae-Young Park, MD, PhD, of CHA University in Korea, and reported by MedPage Today.
This was a phase IIa trial, which is an early-stage study:
- 113 patients were randomly assigned to one of three groups: 50 million cells, 100 million cells, or a placebo injection.
- Each patient received a single injection into the knee joint.
- The average patient was about 62 years old, and about two-thirds were women.
- The study’s main goal was safety. Pain, function, and structural changes were exploratory outcomes.
Key results at 6 months
- Pain and function: WOMAC and KOOS scores, two standard knee scores, improved by about 25 points. That isroughly half of the starting values. Placebo patients also improved, but the treated groups still came out ahead by 15points (WOMAC) and 20 to 21 points (KOOS).
- Self-rated pain: pain dropped 40 to 44 points on a 100-point scale in the treated groups, 24 to 29 points better thanplacebo.
- Responders: 77% to 78% of treated patients met the OMERACT-OARSI response criteria, versus 39% on placebo.The gap was already visible at 4 weeks.
- MRI findings: the treated groups showed some cartilage regeneration and improvement in bone marrowabnormalities, while the placebo group showed progression of cartilage and marrow damage.
- Biomarkers: blood and urine markers of inflammation and cartilage breakdown improved in the treated groups.
- Safety: injection-site reactions occurred in 3 patients (lower dose) and 8 patients (higher dose). No other importanttreatment-related adverse events were reported.
What the study does not prove
The researchers and MedPage Today note several limits, and they matter:
- The study was small and lasted only 6 months. Follow-up will continue for another 6 months plus a 5-year extension.
- It enrolled only patients with moderate knee OA, so results may differ for milder or more severe disease.
- It is not yet known whether repeat treatments are needed to maintain results.
- The study was funded by the developer, Kangstem Biotech, and several authors are company employees.
- OSCA is a specific investigational product. It combines cord blood-derived mesenchymal stem cells with a cartilagematrix taken from pigs. It is not the same as any treatment currently offered at a clinic.
How this relates to stem cell knee treatment at Dream Body Clinic
This trial does not test our treatment, and we do not claim its results apply to our patients. What it does show is that the field is moving in a promising direction. Mesenchymal stem cells (MSCs) are being studied seriously for knee osteoarthritis, with a focus on easing pain and improving the joint environment, not only masking symptoms.
There are some points of overlap. The trial used a dose of 50 million cells, the same dose used in our stem cell knee treatment. Like OSCA, our treatment uses mesenchymal stem cells. Ours are allogeneic MSCs derived from Wharton’s jelly (umbilical cord tissue) and placenta, expanded in our own lab and delivered by ultrasound-guided injection into the knee joint.
Our stem cell knee treatment in Bucerías (Puerto Vallarta area), Mexico includes:
- An on-site open MRI and a full blood panel
- A physician consultation
- An ultrasound-guided injection of 50 million mesenchymal stem cells
- A post-treatment rehab protocol
- Remote follow-up at 3, 6, and 12 months
The price is $3,500 USD for one knee and $7,000 USD for both knees, with everything above included. If the MRI shows you are not a candidate, no treatment fee is charged.
Who may benefit from stem cell knee treatment?
People with knee osteoarthritis, cartilage damage, meniscus tears, or ligament injuries who want a non-surgical option may be candidates. A physician reviews your MRI, bloodwork, and history to decide whether treatment is appropriate. Results vary from patient to patient.
Key takeaways
- A phase 2a trial found that a cell-based knee therapy cut pain by about half over 6 months and showed early signs ofcartilage regeneration on MRI.
- The results are early. The study was small, short, and industry-funded, and it tested a different product from ours.
- Mesenchymal stem cell therapy for knee osteoarthritis is an active area of research.
- Dream Body Clinic offers a 50 million cell MSC knee treatment, with MRI and follow-up included.
A Note From Our Head Physician
By Dr. Arick Barba, Head Physician, Dream Body Clinic
I read this study closely, and here is how I would put it in context for patients.
The results are encouraging. A single injection reduced pain scores by roughly half at 6 months, and the MRI findings pointed toward some cartilage regeneration, while patients on placebo got worse structurally. That is a meaningful signal. It is still an early-phase study. With 113 patients, a 6-month follow-up, moderate-stage disease only, and funding from the developer, it can’t tell us how well this works over the long term or in every patient.
I want to be clear about two things. First, this trial tested a specific investigational product, which is cord blood-derived mesenchymal stem cells combined with a cartilage matrix from pigs. It did not test the cells we use, so we do not claim these outcomes for our patients. Second, our treatment is a different formulation, using allogeneic MSCs from Wharton’s jelly and placenta.
What I do take from this study is that mesenchymal stem cells are a legitimate and active area of osteoarthritis research. In my practice, I decide whether treatment is appropriate after reviewing each patient’s MRI, bloodwork, and history. Some patients are not good candidates, and I will tell them so. Outcomes vary, and no treatment is guaranteed to work.
If you have knee pain and want to talk through your options, I am glad to review your case.
Dr. Arick Barba, Head Physician, Dream Body Clinic
Ready to find out if you’re a candidate? Call (888) 704-3977 for a free consultation, or learn more about our stem cell knee treatment in Puerto Vallarta.
Source: Gever J. “Cell Therapy for Knee Osteoarthritis Reverses Damage in Early Trial.” MedPage Today, November 11, 2026, reporting on Park J-Y, et al., ACR 2026, Abstract LB19. This article is educational and is not medical advice. Individual results vary and are not guaranteed.
